Introduction
============

The lifespan of patients with congenital heart disease (CHD) is longer than before because of improved surveillance, surgical intervention and postoperative care^[@bib1],\ [@bib2]^). CHD patients are vulnerable to arrhythmia events, especially atrial fibrillation (AF)^[@bib3]-[@bib6]^). Indeed, the relationship between CHD and AF occurrence is clear^[@bib3]-[@bib8]^). Patients with CHD-complicated AF may have a higher risk of AF-related complications (stroke, heart failure, and bleeding) resulting in early death; hence, they deserve increased attention^[@bib3]-[@bib8]^). Although the association and the underlying mechanism have been explored previously, early studies primarily focused on the association between a certain type of CHD and concerned the risk of AF among CHD patients who were children and young adults^[@bib3]-[@bib8]^). To add to the existing literature on patients with CHD and AF from a clinical perspective, using National Health Insurance data, the authors conducted this observational-epidemiology study with propensity score matching analysis and multivariable Cox proportional hazards models to evaluate the risk of AF among CHD patients.

Methods
=======

Data Source
-----------

In 1995, the government of Taiwan launched the National Health Insurance (NHI) program, which included claims data and covers more than 99% of the country's population^[@bib9]^). The National Health Research Institutes (NHRI) built the National Health Insurance Research Database (NHIRD). In this retrospective study, we used a subset of the NHIRD containing health care data, including files of the Registry for Catastrophic Illness Patient Database (RCIPD), inpatient claims, and Registry of Beneficiaries. The disease record system in the Taiwan NHI was established according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). The Research Ethics Committee of China Medical University and Hospital in Taiwan approved the study (CMUH-104-REC2-115).

Sampled Participants
--------------------

Patients with a new diagnosis of congenital heart disease (CHD) (ICD-9-CM codes 745.0, 745.1, 745.2, 745.3, 745.4, 745.5, 745.6, 745.7, 746.0, 746.1, 746.2, 746.3, 746.4, 746.5, 746.6, 746.7, 746.8, 747.0, 747.1, 747.2, 747.3, 747.4) were identified from the RCIPD between 2000 and 2010. 19,439 CHD patients with no history of AF (ICD- 9-CM code 427.31) before the index date were selected as the CHD group. Subjects without CHD and AF at baseline were identified as a control cohort. Both cohorts were matched using a 1:1 propensity score to minimize selection bias^[@bib10]^). The propensity score through nearest neighbor matching was calculated using a logistic regression to estimate the probability of the disease status, including gender, age, and comorbidities of hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease (CAD), heart failure, chronic obstructive pulmonary disease (COPD), peripheral arterial occlusion disease (PAOD), chronic renal disease, hyperthyroidism, sleep disorders, gout, cerebrovascular disease, chronic liver disease, chromosome anomaly, epilepsy, congenital respiratory anomaly, mental retardation, rheumatologic disease, and cerebral palsy (**[Fig.1](#F1){ref-type="fig"}**). Therefore, matches were first made within a caliper width of 0.0000001, and then the caliper width was increased for unmatched cases to 0.1. We reconsidered the matching criteria and performed a rematch (greedy algorithm). For each CHD patient, corresponding comparisons were selected based on the nearest propensity score.

![Flowchart of the study design and selection of study subjects](jat-26-670-g001){#F1}

Outcome
-------

All study subjects were followed up until a diagnosis of AF, loss to follow-up, death, withdrawal from the database, or, by the end of 2011, whichever date came first.

Statistical Analysis
--------------------

The distributions of gender, age, and comorbidity (%) between the two cohorts were compared with standardized mean differences. The cumulative incidence of AF for both cohorts and increased aging were plotted using the Kaplan-Meier method, and the log rank test was used to test the curves. The incidence density rates (per 1,000 person-years) were estimated for different risk factors (age, gender, comorbidity) and different CHD types in the two cohorts. Univariable and multivariable Cox proportional hazards regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) of incident AF risk among the CHD patients. All data analyses were executed using SAS Version 9.4 (SAS Institute, Inc., Cary, NC, USA). The level of significance was set to *P* \< .05 and the tests were 2-tailed.

Results
=======

**[Table 1](#T1){ref-type="table"}** showed the gender, age, and comorbidities for patients with CHD (*n* = 19439) and without CHD (*n* = 19439). Most participants were aged \< 18 years (68.8% vs 66.7% in both cohorts). The mean ages of the CHD and non-CHD control cohorts were 14.9 (±19.3 years) and 14.7 (±21.5 years), respectively. Comorbidities, including hypertension, diabetes mellitus, hyperlipidemia, CAD, COPD, hyperthyroidism, sleep disorders, gout, cerebrovascular disease, chronic liver disease, and rheumatologic disease were comparable and significantly different between the two cohorts. The mean follow-up duration for the CHD and non-CHD cohorts was 6.10±3.31 and 6.01±3.17 years, respectively (data not shown).

###### 

Table 1. Demographic characteristics and comorbidities in patients with and without congenital heart disease Congenital heart disease

  --------------------------------------------------------------------------------------------------------------------
  Variables                          Congenital heart disease   Standardized\                                  
                                                                mean\                                          
                                                                difference^[§](#t1fna){ref-type="table-fn"}^   
  ---------------------------------- -------------------------- ---------------------------------------------- -------
  Gender                                                                                                       

    Women                            9728 (50.0)                10570 (54.4)                                   0.09

    Men                              9711 (50.0)                8869 (45.6)                                    0.09

  Age stratified                                                                                               

    \<18                             12959 (66.7)               13373 (68.8)                                   0.05

    18--34                           2709 (13.9)                2771 (14.3)                                    0.01

    35--49                           1641 (8.44)                1685 (8.67)                                    0.01

    50+                              2130 (11.0)                1610 (8.28)                                    0.09

  Age, mean±SD^a^                    14.7±21.5                  14.9±19.3                                      0.09

  Comorbidity                                                                                                  

    Hypertension                     1824 (9.38)                623 (3.20)                                     0.26

    Diabetes mellitus                819 (4.21)                 264 (1.36)                                     0.17

    Hyperlipidemia                   698 (3.59)                 218 (1.12)                                     0.16

    CAD                              1227 (6.31)                588 (3.02)                                     0.16

    Heart failure                    1513 (7.78)                1028 (5.29)                                    0.10

    COPD                             359 (1.85)                 112 (0.58)                                     0.12

    PAOD                             80 (0.41)                  41 (0.21)                                      0.04

    Chronic renal disease            105 (0.54)                 39 (0.20)                                      0.06

    Hyperthyroidism                  355 (1.83)                 50 (0.26)                                      0.16

    Sleep disorders                  306 (1.57)                 46 (0.24)                                      0.14

    Gout                             294 (1.51)                 81 (0.42)                                      0.11

    Cerebrovascular disease          540 (2.78)                 152 (0.78)                                     0.15

    Chronic liver disease            839 (4.32)                 141 (0.73)                                     0.23

    Chromosome anomaly               159 (0.82)                 252 (1.30)                                     0.05

    Epilepsy                         153 (0.79)                 65 (0.33)                                      0.06

    Congenital respiratory anomaly   9 (0.05)                   34 (0.17)                                      0.04

    Mental retardation               32 (0.16)                  30 (0.15)                                      0.003

    Rheumatologic disease            559 (2.88)                 141 (0.73)                                     0.16

    Cerebral palsy                   129 (0.66)                 24 (0.12)                                      0.09
  --------------------------------------------------------------------------------------------------------------------

CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; PAOD, peripheral arterial occlusive disease

A standardized mean difference of ≤ 0.10 indicates a negligible difference between the two cohorts.

The cumulative incidence of AF was significantly higher in the CHD cohort than in the non- CHD cohort (**[Fig.2](#F2){ref-type="fig"}**; *p* \< 0.001). **[Table 2](#T2){ref-type="table"}** showed that the overall AF density rates were 2.06 and 0.96 per 1,000 person-years for the CHD cohort and the non-CHD cohort, respectively. After controlling for confounding factors, the adjusted hazard ratio (aHR) of AF was 4.23 (95% CI 3.31--5.41) in the CHD cohort compared to the non-CHD cohort. Compared to patients aged \< 18 years, the risk of AF was 16.6-fold higher in those aged 18--34 years (95% CI 7.51--36.7), 58.5-fold higher in those 35--49 years (95% CI 27.8--122.8), and 231.9-fold higher in those aged ≥ 50 years (95% CI 113.3--474.5). AF risk was significantly higher in patients with CAD (aHR=1.43, 95% CI 1.10--1.85), heart failure (aHR=2.35, 95% CI 1.84--3.01), and chronic renal disease (aHR=2.29, 95% CI 1.30--4.05) compared to subjects without these comorbidities.

![Cumulative incidence curves of new-onset atrial fibrillation for groups with and without congenital heart disease](jat-26-670-g002){#F2}

###### 

Table 2. The incidence and risk factors for atrial fibrillation

  Variable                           Event   PY       Rate^[\#](#t2fnb){ref-type="table-fn"}^   Crude HR (95% CI)                                         Adjusted HR^[\$](#t2fnc){ref-type="table-fn"}^ (95% CI)
  ---------------------------------- ------- -------- ----------------------------------------- --------------------------------------------------------- -----------------------------------------------------------
  Congenital heart disease                                                                                                                                
    No                               112     116778   0.96                                      1.00                                                      1.00
    Yes                              244     118666   2.06                                      2.17 (1.73, 2.71)[\*\*\*](#t2fnf){ref-type="table-fn"}    4.23 (3.31, 5.41)[\*\*\*](#t2fnf){ref-type="table-fn"}
  Age group, years                                                                                                                                        
    \< 18                            8       169387   0.05                                      1.00                                                      1.00
    18--34                           26      31159    0.83                                      17.3 (7.82, 38.2)[\*\*\*](#t2fnf){ref-type="table-fn"}    16.6 (7.51, 36.7)[\*\*\*](#t2fnf){ref-type="table-fn"}
    35--49                           57      17829    3.20                                      65.5 (31.2, 137.3)[\*\*\*](#t2fnf){ref-type="table-fn"}   58.5 (27.8, 122.8)[\*\*\*](#t2fnf){ref-type="table-fn"}
    50+                              265     17070    15.5                                      308.6 (152.6, 624)[\*\*\*](#t2fnf){ref-type="table-fn"}   231.9 (113.3, 474.5)[\*\*\*](#t2fnf){ref-type="table-fn"}
  Gender                                                                                                                                                  
    Women                            191     121781   1.57                                      1.00                                                      1.00
    Men                              165     113663   1.45                                      0.94 (0.76, 1.15)                                         
  Comorbidity                                                                                                                                             
    Hypertension                                                                                                                                          
      No                             237     224185   1.06                                      1.00                                                      1.00
      Yes                            119     11259    10.6                                      9.16 (7.34, 11.4)[\*\*\*](#t2fnf){ref-type="table-fn"}    1.07 (0.82, 1.39)
    Diabetes mellitus                                                                                                                                     
      No                             307     230839   1.33                                      1.00                                                      1.00
      Yes                            49      4606     10.6                                      7.10 (5.24, 9.61)[\*\*\*](#t2fnf){ref-type="table-fn"}    0.86 (0.62, 1.20)
    Hyperlipidemia                                                                                                                                        
    No                               326     231081   1.41                                      1.00                                                      1.00
    Yes                              30      4363     6.88                                      4.47 (3.07, 6.50)[\*\*\*](#t2fnf){ref-type="table-fn"}    0.70 (0.47, 1.04)
    CAD                                                                                                                                                   
      No                             238     227367   1.05                                      1.00                                                      1.00
      Yes                            118     8077     14.6                                      12.7 (10.2, 15.9)[\*\*\*](#t2fnf){ref-type="table-fn"}    1.43 (1.10, 1.85)[\*\*](#t2fne){ref-type="table-fn"}
    Heart failure                                                                                                                                         
      No                             222     223237   0.99                                      1.00                                                      1.00
      Yes                            134     12208    11.0                                      10.3 (8.34, 12.8)[\*\*\*](#t2fnf){ref-type="table-fn"}    2.35 (1.84, 3.01)[\*\*\*](#t2fnf){ref-type="table-fn"}
    COPD                                                                                                                                                  
      No                             321     233506   1.37                                      1.00                                                      1.00
      Yes                            35      1939     18.1                                      11.6 (8.21, 16.5)[\*\*\*](#t2fnf){ref-type="table-fn"}    1.39 (0.95, 2.01)
    PAOD                                                                                                                                                  
      No                             347     234896   1.48                                      1.00                                                      1.00
      Yes                            9       548      16.4                                      10.2 (5.27, 19.8)[\*\*\*](#t2fnf){ref-type="table-fn"}    1.81 (0.92, 3.56)
    Chronic renal disease                                                                                                                                 
      No                             343     234948   1.46                                      1.00                                                      1.00
      Yes                            13      497      26.2                                      15.1 (8.69, 26.4)[\*\*\*](#t2fnf){ref-type="table-fn"}    2.29 (1.30, 4.05)\*\*
    Hyperthyroidism                                                                                                                                       
      No                             352     233154   1.51                                      1.00                                                      1.00
      Yes                            4       2291     1.75                                      1.12 (0.42, 3.00)                                         
    Sleep disorders                                                                                                                                       
      No                             350     233835   1.50                                      1.00                                                      1.00
      Yes                            6       1610     3.73                                      2.23 (1.00, 5.00)                                         
    Gout                                                                                                                                                  
      No                             335     233747   1.43                                      1.00                                                      1.00
      Yes                            21      1698     12.4                                      7.83 (5.03, 12.2)[\*\*\*](#t2fnf){ref-type="table-fn"}    1.30 (0.82, 2.07)
    Cerebrovascular disease                                                                                                                               
      No                             330     232536   1.42                                      1.00                                                      1.00
      Yes                            26      2908     8.94                                      5.55 (3.72, 8.28)[\*\*\*](#t2fnf){ref-type="table-fn"}    0.78 (0.51, 1.20)
    Chronic liver disease                                                                                                                                 
      No                             326     230713   1.41                                      1.00                                                      1.00
      Yes                            30      4732     6.34                                      4.15 (2.85, 6.03)[\*\*\*](#t2fnf){ref-type="table-fn"}    1.23 (0.83, 1.82)
    Chromosome anomaly                                                                                                                                    
      No                             356     233085   1.53                                      1.00                                                      1.00
      Yes                            0       2359     0.00                                      \-                                                        
    Epilepsy                                                                                                                                              
      No                             356     234360   1.52                                      1.00                                                      1.00
      Yes                            0       1085     0.00                                      \-                                                        
    Congenital respiratory anomaly                                                                                                                        
      No                             356     235250   1.51                                      1.00                                                      
      Yes                            0       195      0.00                                      \-                                                        
    Mental retardation                                                                                                                                    
      No                             354     235118   1.51                                      1.00                                                      1.00
      Yes                            2       326      6.13                                      3.86 (0.96, 15.5)                                         1.00
    Rheumatologic disease                                                                                                                                 
      No                             331     231488   1.43                                      1.00                                                      1.00
      Yes                            25      3956     6.32                                      4.33 (2.89, 6.51)[\*\*\*](#t2fnf){ref-type="table-fn"}    1.00
    Cerebral palsy                                                                                                                                        
      No                             355     234510   1.51                                      1.00                                                      1.23 (0.81, 1.87)
      Yes                            1       934      1.07                                      0.71 (0.10, 5.06)                                         1.00

CAD, coronary artery disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; PAOD, peripheral arterial occlusive disease; PY, person-years;

Incidence rate per 1,000 person-years;

Multivariable analysis included age, and comorbidity of hypertension, diabetes mellitus, hyperlipidemia, CAD, heart failure, COPD, PAOD, chronic renal disease, gout, cerebrovascular disease, chronic liver disease, and rheumatologic disease;

*p* \< 0.05

*p* \< 0.01

*p* \< 0.001

AF risks were higher in patients with different types of CHD, namely transposition of the great vessels (aHR=8.61, 95% CI 1.19--62.5), Tetralogy of Fallot (aHR=7.03, 95% CI 3.48--14.2), ventricular septal defect (aHR=2.98, 95% CI 2.03--4.38), ostium secundum type atrial septal defect (aHR=6.20, 95% CI 4.71--8.15), Atrioventricular septal defect (aHR = 6.94, 95% CI 2.51-19.2), two-chambered heart (aHR =134.7, 95% CI 18.5--982.9), Ebsteinfs anomaly (aHR=6.09, 95% CI 2.47--15.0), congenital insufficiency of the aortic valve (aHR=3.55, 95% CI 1.79--7.04), other specified congenital anomalies of heart (aHR=2.74, 95% CI 1.26--5.95), patent ductus arteriosus (aHR=5.83, 95% CI 3.33--10.2), and coarctation of the aorta (aHR=8.06, 95% CI 1.97--33.0) (**[Table 3](#T3){ref-type="table"}**). The cumulative incidence of AF was much higher in CHD patients than in non-CHD patients and increased with age (**[Fig.3](#F3){ref-type="fig"}**; *p* \< 0.001).

###### 

Table 3. Incidence and hazard ratios of AF between individuals with difference types congenital heart disease and without congenital heart disease

  Variable                                          *N*     Event   PY       Rate^\#^   Crude HR (95% CI)          Adjusted HR^&^ (95% CI)
  ------------------------------------------------- ------- ------- -------- ---------- -------------------------- ---------------------------
  Congenital heart disease                                                                                         
    None                                            19439   112     116778   0.96       1 (Reference)              1 (Reference)
    Common truncus                                  24      0       132      0.00       \-                         \-
    Transposition of the great vessels              272     1       1146     0.87       0.86 (0.12, 6.12)          8.61 (1.19, 62.5)\*
    Tetralogy of Fallot                             1250    9       7605     1.18       1.26 (0.64,2 .48)          7.03 (3.48, 14.2)\*\*\*
    Common ventricle                                49      0       203      0.00       \-                         
    Ventricular septal defec                        7308    41      49795    0.82       0.90 (0.63,1 .28)          2.98 (2.03, 4.38)\*\*\*
    Ostium secundum type atrial septal defect       5274    139     30453    4.56       4.71 (3.67, 6.03)\*\*\*    6.20 (4.71, 8.15)\*\*\*
    Atrioventricular septal defect                  221     4       1100     3.64       3.64 (1.34, 9.87)\*        6.94 (2.51, 19.2)\*\*\*
    Two-chambered heart                             5       1       38       26.2       29.9 (4.17, 214.1)\*\*\*   134.7 (18.5, 982.9)\*\*\*
    Anomalies of pulmonary valve congenital         765     2       4580     0.44       0.46 (0.11, 1.87)          3.31 (0.81, 13.5)
    Tricuspid atresia and stenosis, congenital      38      0       201      0.00       \-                         
    Ebstein's anomaly                               135     5       804      6.22       6.52 (2.66, 16.0)\*\*\*    6.09 (2.47, 15.0)\*\*\*
    Congenital stenosis of aortic valve             372     7       1888     3.71       3.68 (1.72, 7.90)\*\*\*    1.05 (0.49, 2.28)
    Congenital insufficiency of the aortic valve    200     9       914      9.85       9.41 (4.77, 18.6)\*\*\*    3.55 (1.79, 7.04)\*\*\*
    Congenital mitral stenosis                      20      0       98       0.00                                  
    Congenital mitral insufficiency                 102     2       560      3.57       3.65 (0.90, 14.8)          3.52 (0.86, 14.4)
    Hypoplastic left heart syndrome                 34      0       22       0.00                                  
    Other specified congenital anomalies of heart   302     7       1297     5.40       5.04 (2.35, 10.8)\*\*\*    2.74 (1.26, 5.95)\*
    Patent ductus arteriosus                        1692    15      10581    1.42       1.51 (0.88, 2.58)          5.83 (3.33, 10.2)\*\*\*
    Co-arctation of the aorta                       188     2       913      2.19       2.16 (0.53, 8.74)          8.06 (1.97, 33.0)\*\*
    Other congenital anomalies of the aorta         750     0       3891     0.00                                  
    Congenital anomalies of the pulmonary artery    326     0       1937     0.00                                  
    Anomalies of the great veins                    112     0       506      0.00                                  

CAD, coronary artery disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; PAOD, peripheral arterial occlusive disease; PY, person-years;

Incidence rate per 1,000 person-years;

Multivariable analysis included age, and comorbidity of hypertension, diabetes mellitus, hyperlipidemia, CAD, heart failure, COPD, PAOD, chronic renal disease, gout, cerebrovascular disease, chronic liver disease, and rheumatologic disease;

*p* \< 0.05

*p* \< 0.01

*p* \< 0.001.
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Discussion
==========

This retrospective cohort study was conducted within the Taiwan National Insurance Database. The authors assessed the risk of AF by CHD using a large number of samples and a propensity-matching procedure. Multivariable Cox models showed increased AF risk in CHD patients, and that was statistically significant.

The link between CHD and risk of incident AF has been demonstrated, mainly through underlying medical comorbidities, post-surgery fibrosis, cardiac remodeling, or increased loading condition^[@bib3]-[@bib8],\ [@bib11]-[@bib13]^). This study is different from other investigations examining the association between CHD and AF in that it does not focus on AF during subsequent years for a certain type of CHD or a specified age group, making this study unique, relevant, and informative^[@bib3]-[@bib8],\ [@bib11]-[@bib13]^).

The incidence of new-onset AF is significantly lower than that reported in previous studies^[@bib3]-[@bib8],\ [@bib11]-[@bib13]^). Moreover, the incidence of comorbidities at risk for the occurrence of AF is very low in both groups. Some researchers might argue that patients who were hospitalized with a CHD, despite propensity matching on some important variables, would still have a higher risk of AF most likely related to more severe underlying disease not corrected for in matching. Moreover, it is difficult to conclude that a two-chambered heart conferred the highest risk of incident AF compared to other CHDs since there were only five patients with two-chambered hearts. The results should be interpreted with high caution given the very low event rates presented in this study.

Numerous studies have shown that AF patients have much higher morbidity and mortality compared to the general population^[@bib14],\ [@bib15]^). As reported in this study, CHD is inextricably linked to incident AF. Given that identifying AF and a high risk of stroke is of great importance, CHD patients should be approached with caution so that early detection and intervention strategy could be applied^[@bib16],\ [@bib17]^).

Several aspects of the study strengths deserved to be highlighted. First, this nationwide project addressed almost 100% of Taiwan's population. Second, this study has a large population, with 19,439 patients in the CHD and in the comparison group. Finally, the methodology is appropriate for the topic. Patients with and without CHD have few differences, making the correlation highly reliable.

Limitations
===========

Although this study investigates a topic of high interest, there are still several methodological concerns which might limit generalization of the results. The principal limitation, however, is the relatively small prevalence of CHD in the general population and the consequent relatively modest priority. Second, because of the limitations of the national health insurance database, the authors did not mention the methods of AF detection. There was no information on the type of AF (paroxysmal or non-paroxysmal), and this might be a potential bias. In addition, the size of the atrium measured by echocardiography or magnetic resonance was not available although the occurrence of AF is related to the size of the atrium. Third, despite propensity matching, some investigators might be concerned about residual confounding. Finally, all diagnoses were defined using the ICD code, so the reliability might be challenged. However, many validation studies involving this administrative data have been reported, and the result was highly convincing^[@bib18]-[@bib20]^).

Conclusion
==========

CHD is significantly associated with new onset of AF.
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